National HPV Vaccination Campaign achieves 8 million adolescent girl vaccinations in 6 months

Updated 13 Sept 2026

Contents4

Hindustan Times - India · 13 Sept 2026 · 2 min read
Prelims · Health Mains · GS2 Governance High relevance

India's National HPV Vaccination Campaign has vaccinated 8 million adolescent girls in six months, significantly advancing cervical cancer prevention and public health infrastructure.

Key points

National HPV Vaccination Campaign launched on February 28, 2026, aims to prevent cervical cancer by vaccinating 14-year-old girls through government health facilities.

Uttar Pradesh leads with 2.2 million vaccinations, followed by Gujarat, Madhya Pradesh, and Mizoram achieving 100% coverage of their target populations.

The campaign utilizes India's digital health infrastructure, including the U-WIN platform, for real-time monitoring and resource allocation.

Cervical cancer accounts for 123,000 new cases annually in India, representing one-fifth of global cases and one-quarter of global deaths.

[GS2-Governance] The campaign demonstrates effective intergovernmental coordination, with states adopting context-specific approaches for rural and remote areas.

[GS3-Science and Technology] WHO-endorsed single-dose HPV vaccine regimen shows efficacy comparable to multi-dose regimens, as per Lancet studies.

The initiative engages ASHAs and ANMs for community mobilization, addressing vaccine hesitancy through parental consent and awareness programs.

Adverse Events Following Immunization (AEFI) protocols are in place, linking vaccination sites to 24×7 healthcare facilities for management.

India's annual cohort of 14-year-old girls is approximately 12 million, as per Registrar General of India 2021 estimates.

Way Forward: Expand vaccination to include boys for herd immunity, integrate HPV education into school curricula, and enhance cold chain infrastructure for rural areas.

Key terms

Human Papillomavirus (HPV)
A group of viruses causing cervical cancer and other cancers. HPV vaccination is a primary prevention strategy recognized by WHO, with India's campaign aligning with global health targets under SDG 3.4 for reducing premature mortality from non-communicable diseases.
U-WIN platform
India's digital immunization registry under the Universal Immunization Programme, enabling real-time tracking of vaccination coverage and beneficiary management. It represents the digital transformation of public health infrastructure under the National Digital Health Mission.
ASHAs (Accredited Social Health Activists)
Community health workers under the National Health Mission, crucial for last-mile healthcare delivery. Their role in HPV vaccination demonstrates India's decentralized public health approach and women's empowerment in healthcare.
Adverse Events Following Immunization (AEFI)
A surveillance system mandated under the National Immunization Programme to monitor vaccine safety. Its robust implementation is critical for maintaining public trust in vaccination programs and addressing vaccine hesitancy.

Practice question

Critically evaluate the significance of India's National HPV Vaccination Campaign in strengthening public health infrastructure and achieving universal healthcare goals. (250 words, 15 marks)

GS2 15 marks 250 words Mains

Key terms to include: U-WIN platform ASHAs ANMs Adverse Events Following Immunization (AEFI) SDG 3.4 herd immunity cold chain infrastructure vaccine hesitancy

Answer framework

Introduction

Briefly introduce the National HPV Vaccination Campaign, its objectives, and its rapid scale-up to vaccinate 8 million adolescent girls in six months.

Public Health Infrastructure Strengthening

Utilization of digital platforms like U-WIN for real-time monitoring and efficient resource allocation.

Enhancement of cold chain infrastructure to ensure vaccine efficacy, especially in rural areas.

Integration with existing health systems, leveraging ASHAs and ANMs for last-mile delivery.

Achieving Universal Healthcare Goals

Alignment with SDG 3.4 to reduce premature mortality from non-communicable diseases like cervical cancer.

Demonstration of intergovernmental coordination and context-specific approaches for diverse populations.

Potential to expand to include boys for herd immunity, furthering universal health coverage.

Challenges and Limitations

Addressing vaccine hesitancy through sustained awareness campaigns and parental consent mechanisms.

Ensuring equitable access in remote and underserved regions to avoid disparities in coverage.

Maintaining robust AEFI protocols to manage adverse events and sustain public trust.

Conclusion

Emphasize the campaign's role as a model for future public health initiatives, suggesting expansion to other preventable diseases and continuous improvement in digital and physical infrastructure.

Fact check

All facts verified